Teladoc Health financials
$5.89−3.28%
Close Sep 28, 2026 · split-adjustedRevenue
Net income
Income statement & cash flow
| Quarter | Q2 '26 Jun 30 | Q1 '26 Mar 31 | Q4 '25 Dec 31 | Q3 '25 Sep 30 | Q2 '25 Jun 30 | Q1 '25 Mar 31 | Q4 '24 Dec 31 | Q3 '24 Sep 30 | Q2 '24 Jun 30 | Q1 '24 Mar 31 | Q4 '23 Dec 31 | Q3 '23 Sep 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $606.9M | $613.8M | $642.3M | $626.4M | $631.9M | $629.4M | $640.5M | $640.5M | $642.4M | $646.1M | $660.5M | $660.2M |
| Gross profit | $416.1M | $416.3M | $445.2M | $439.3M | $441.4M | $432.5M | $451.6M | $460.8M | $454.4M | $451.6M | $467.1M | $474.3M |
| Gross margin | 68.6% | 67.8% | 69.3% | 70.1% | 69.8% | 68.7% | 70.5% | 71.9% | 70.7% | 69.9% | 70.7% | 71.8% |
| Operating income | -$35.4M | -$61.8M | -$36.0M | -$52.0M | -$51.7M | -$120.6M | -$48.2M | -$44.4M | -$841.1M | -$87.1M | -$35.1M | -$64.7M |
| Net income | -$38.9M | -$63.8M | -$25.1M | -$49.5M | -$32.7M | -$93.0M | -$48.4M | -$33.3M | -$837.7M | -$81.9M | -$28.9M | -$57.1M |
| Net margin | −6.4% | −10.4% | −3.9% | −7.9% | −5.2% | −14.8% | −7.6% | −5.2% | −130.4% | −12.7% | −4.4% | −8.6% |
| Diluted EPS | $-0.21 | $-0.36 | $-0.14 | $-0.28 | $-0.19 | $-0.53 | $-0.28 | $-0.19 | $-4.92 | $-0.49 | $-0.17 | $-0.35 |
| EBITDA | $56.4M | $43.6M | $67.9M | $52.9M | $47.0M | $32.9M | $47.4M | $49.2M | $47.4M | $20.8M | -$29.9M | $35.8M |
| Operating cash flow | $64.7M | $9.5M | $87.7M | $99.3M | $91.4M | $15.9M | $85.9M | $110.2M | $88.7M | $8.9M | $130.1M | $105.6M |
| Free cash flow | $63.7M | $7.9M | $53.4M | $67.9M | $90.2M | $13.2M | $56.3M | $79.0M | $60.9M | -$26.6M | $93.6M | $68.0M |
| Diluted shares | 181.0M | 179.1M | 177.9M | 176.9M | 175.9M | 174.2M | 172.8M | 171.5M | 170.2M | 167.7M | 166.1M | 165.1M |
Balance sheet
| Period end | Jun 30 | Mar 31 | Dec 31 | Sep 30 | Jun 30 | Mar 31 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $774.3M | $750.7M | $781.1M | $726.2M | $679.6M | $1.19B |
| Short-term investments | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Total debt | $996.7M | $995.8M | $994.9M | $994.0M | $993.2M | $1.54B |
| Total assets | $2.76B | $2.81B | $2.86B | $2.88B | $2.89B | $3.44B |
| Total liabilities | $1.45B | $1.47B | $1.47B | $1.49B | $1.47B | $2.02B |
| Shareholders' equity | $1.31B | $1.34B | $1.39B | $1.39B | $1.42B | $1.43B |
From SEC filings via Massive. Fiscal periods follow the company's own calendar; free cash flow is operating cash flow minus capital expenditure.
Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology